Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSearching for the cheapest Mounjaro 7.5mg online in the UK is a reasonable instinct — but private pricing for this prescription medicine works differently from most online purchases, and the headline figure rarely tells the whole story. Mounjaro (tirzepatide) is a prescription-only medicine, which means every legitimate supply in the UK must follow a clinical assessment by a qualified prescriber. Since Eli Lilly raised UK list prices in September 2025, monthly costs for the higher doses have risen sharply — reported figures for the 7.5mg tier typically sit somewhere between £150 and £260 per pen across private providers, though the range shifts depending on what a given service actually bundles in. A fuller breakdown of Mounjaro pricing across all doses is worth reading before you compare quotes.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average body-weight reductions of around 20–21% over 72 weeks at the highest tirzepatide dose, with meaningful losses building at intermediate doses as the titration schedule progresses. NICE's appraisal of tirzepatide (TA1026) confirmed the medicine's clinical value and set eligibility criteria for adults managing obesity alongside a weight-related condition. What the evidence makes clear is that 7.5mg sits in the middle of the licensed range, above the 2.5mg and 5mg starting doses, which exist largely to let the body adjust, and below the 10mg, 12.5mg and 15mg maintenance doses where the trial's most substantial results accumulated.
That context matters for pricing. Someone buying a 7.5mg pen is typically mid-titration, not at a final dose. The clinical picture at that point, including how well the dose is being tolerated and whether a further increase makes sense, is something a prescriber should be reviewing before each repeat supply. The full Mounjaro overview explains how the titration pathway works and why that review matters at every step.
One thing worth setting aside quickly: the idea that a higher dose automatically means a disproportionately higher price from every provider. Pricing structures vary considerably, and the gap between 5mg and 7.5mg costs is not uniform across the market. What matters more than the dose-specific price is what clinical infrastructure sits behind it.
The reported range for private Mounjaro supply since the Lilly price increase reflects the manufacturer's higher list prices (widely covered in August 2025) but individual providers set their own rates on top. That means a quoted figure can exclude quite a few things. Consultation fees are sometimes charged separately, particularly on platforms that treat the clinical assessment as an add-on service rather than part of the product. Prescription fees are another common line item. Delivery, especially tracked next-working-day courier delivery, is frequently extra.
Aftercare is the gap that catches people most by surprise. A titration schedule for Mounjaro runs across multiple months, and questions come up, about side effects, missed doses, what to do before a planned procedure. Some services charge for clinical support beyond the initial order; others simply don't offer it in a structured way. The guide to finding a legitimate Mounjaro supplier in the UK covers what to check before committing to any provider.
There is also the question of the supply chain itself. Mounjaro purchased through an unverified seller, regardless of price, carries real risk. The MHRA has documented large seizures of counterfeit weight-loss pens and raided illicit manufacturing operations producing fake tirzepatide. Any pharmacy dispensing Mounjaro legally in the UK should be verifiable on the GPhC register, and if a seller cannot be found there, price is not the relevant consideration.
We are not the cheapest Mounjaro provider in the UK. That is a deliberate position. One transparent price covers the free consultation, the prescription, the medicine itself, next-working-day DPD delivery, and seven-day aftercare, nothing invoiced separately afterwards. The treatment page shows current pricing clearly; per-pen figures are not printed in body copy because they move as the market adjusts, and we would rather you see the live number than a stale one in an article.
Every consultation at nume is personally reviewed by a GPhC-registered Independent Prescriber. That includes repeat orders and dose changes, both require a clinical look, not an automatic approval. Our pharmacy holds GPhC premises registration 9012878, verifiable directly on the register. Medicines move through the licensed UK supply chain via authorised Eli Lilly relationships. There are no subscriptions, no auto-renewals, and no discount codes, for a prescription medicine, a discount code from an unverified source is one of the cleaner red flags that something is off.
For context on how 7.5mg fits against other dose-specific costs, the 5mg cost guide and the 10mg equivalent cover those tiers in the same detail. The weight-loss treatment overview is a useful starting point if you are still deciding between options.
For most purchases, lowest price is a reasonable proxy for value. For a prescription medicine obtained through an online pharmacy, it is the wrong test. The questions that matter are: is the pharmacy registered with the GPhC? Is a qualified prescriber making the clinical decision? Is the supply chain authorised? Is there someone to contact if something doesn't feel right after the first injection?
A small saving on the 7.5mg pen price is not worth much if the answer to any of those questions is unclear. The MHRA's Yellow Card service accepts reports of both suspected side effects and suspect sellers, worth knowing exists. Our FAQs address the questions our prescribers hear most often about starting and continuing treatment, and our clinical team is there if you want to understand more about how the service works before you begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.